- Home
- ESPR vs HVT Comparison
ESPR vs HVT Comparison
Compare ESPR & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- HVT
- Stock Information
- Founded
- ESPR 2008
- HVT 1885
- Country
- ESPR United States
- HVT United States
- Employees
- ESPR N/A
- HVT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- HVT Other Specialty Stores
- Sector
- ESPR Health Care
- HVT Consumer Discretionary
- Exchange
- ESPR Nasdaq
- HVT Nasdaq
- Market Cap
- ESPR 305.0M
- HVT 336.0M
- IPO Year
- ESPR 2013
- HVT N/A
- Fundamental
- Price
- ESPR $0.95
- HVT $17.71
- Analyst Decision
- ESPR Buy
- HVT Strong Buy
- Analyst Count
- ESPR 7
- HVT 1
- Target Price
- ESPR $6.07
- HVT $45.00
- AVG Volume (30 Days)
- ESPR 5.5M
- HVT 153.5K
- Earning Date
- ESPR 05-06-2025
- HVT 04-30-2025
- Dividend Yield
- ESPR N/A
- HVT 7.23%
- EPS Growth
- ESPR N/A
- HVT N/A
- EPS
- ESPR N/A
- HVT 1.19
- Revenue
- ESPR $332,314,000.00
- HVT $722,899,000.00
- Revenue This Year
- ESPR $5.17
- HVT $5.31
- Revenue Next Year
- ESPR N/A
- HVT $8.06
- P/E Ratio
- ESPR N/A
- HVT $14.88
- Revenue Growth
- ESPR 185.66
- HVT N/A
- 52 Week Low
- ESPR $0.93
- HVT $17.01
- 52 Week High
- ESPR $3.94
- HVT $33.04
- Technical
- Relative Strength Index (RSI)
- ESPR 22.73
- HVT 38.54
- Support Level
- ESPR $0.93
- HVT $17.01
- Resistance Level
- ESPR $1.06
- HVT $18.90
- Average True Range (ATR)
- ESPR 0.09
- HVT 1.07
- MACD
- ESPR -0.02
- HVT -0.10
- Stochastic Oscillator
- ESPR 3.57
- HVT 19.18
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.